Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 79803

4 recalled-product records grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
April 11, 2018
Product types
Drug
Classifications
Class II
Statuses
Terminated
Recalling firm wording
Premier Pharmacy Labs Inc

Dossier provenance

Source snapshots represented here

  • openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

4 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 4

Morphine Sulfate 2 mg/mL PF Injection. 1 mL in a 3ml Sterile Single-Dose Syringe. 8265 Commerical Way Weeki Wachee, FL 34613. NDC 69623-129-10

D-0699-2018
Recall number
D-0699-2018
Initiated
April 11, 2018
Classification
Class II
Status
Terminated
Recalling firm
Premier Pharmacy Labs Inc
Quantity
4555 syringes

App-derived interpretation

Microbial contamination reason.microbial_contamination · v1.0.0
Microbial contamination
Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility:Microbial contamination was detected during routine testing of subsequent unreleased product lots due to interaction between the product syringe and tamper evident container closure, which may result in the potential introduction of microorganisms into the products.

Code information

Lots: MOR030518IJDSA, MOR030518IJDSB, MOR030518IJDSC, MOR030518IJDSD, MOR030518IJDSE BUD: 06/03/2018;

Distribution pattern

Nationwide in the USA

drug · product 2 of 4

Morphine Sulfate 4 mg/mL PF Injection. 1 mL in a 3ml Sterile Single-Dose Syringe. 8265 Commerical Way Weeki Wachee, FL 34613. NDC 69623-127-10

D-0700-2018
Recall number
D-0700-2018
Initiated
April 11, 2018
Classification
Class II
Status
Terminated
Recalling firm
Premier Pharmacy Labs Inc
Quantity
4192 syringes

App-derived interpretation

Microbial contamination reason.microbial_contamination · v1.0.0
Microbial contamination
Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility:Microbial contamination was detected during routine testing of subsequent unreleased product lots due to interaction between the product syringe and tamper evident container closure, which may result in the potential introduction of microorganisms into the products.

Code information

Lots: MOR022318NWDSA, MOR022318NWDSB, MOR022318NWDSC, MOR022318NWDSD, MOR022318NWDSE BUD: 05/24/2018

Distribution pattern

Nationwide in the USA

drug · product 3 of 4

Hydromorphone HCl 1 mg/mL PF INJ. 1mL in a 3mL Sterile Single-Dose Syringe. 8265 Commercial Way Weeki Wachee, FL 34613 NDC 69623-249-10

D-0701-2018
Recall number
D-0701-2018
Initiated
April 11, 2018
Classification
Class II
Status
Terminated
Recalling firm
Premier Pharmacy Labs Inc
Quantity
3570 syringes

App-derived interpretation

Microbial contamination reason.microbial_contamination · v1.0.0
Microbial contamination
Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility:Microbial contamination was detected during routine testing of subsequent unreleased product lots due to interaction between the product syringe and tamper evident container closure, which may result in the potential introduction of microorganisms into the products.

Code information

Lots: HYD030118IJDSA, HYD030118IJDSB, HYD030118IJDSD, HYD030118IJDSE BUD: 05/30/2018

Distribution pattern

Nationwide in the USA

drug · product 4 of 4

NEOstigmine Methylsulfate (1 mg/mL) 3mg per 3mL. 3mL Single Dose Syringe. Premier Pharmacy Labs. 8265 Commercial Way Weeki Wachee, FL 34613 NDC 69623-234-14.

D-0702-2018
Recall number
D-0702-2018
Initiated
April 11, 2018
Classification
Class II
Status
Terminated
Recalling firm
Premier Pharmacy Labs Inc
Quantity
600 syringes

App-derived interpretation

Microbial contamination reason.microbial_contamination · v1.0.0
Microbial contamination
Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility:Microbial contamination was detected during routine testing of subsequent unreleased product lots due to interaction between the product syringe and tamper evident container closure, which may result in the potential introduction of microorganisms into the products.

Code information

Lot: NEO022218SVDS BUD: 8/21/2018

Distribution pattern

Nationwide in the USA